IMAX Stock Tickeron detected bullish Stock Pattern: Broadening Wedge Descending IMAX on August 27, 2025, netting in a 11.43% gain over 4 weeks

GET DAILY SIGNALS

Get AI intraday signals

IMAX - Imax Corp

Ticker: IMAX

Company: Imax

Gain: +11.43%

Confirmed: 08/27/25

Succeeded: 08/27/25

Total length: 29 days

IMAX in +4.70% Uptrend, rising for three consecutive days on August 27, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IMAX advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 15, 2025. You may want to consider a long position or call options on IMAX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IMAX just turned positive on August 14, 2025. Looking at past instances where IMAX's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

IMAX moved above its 50-day moving average on August 22, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IMAX crossed bullishly above the 50-day moving average on August 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IMAX broke above its upper Bollinger Band on August 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.902) is normal, around the industry mean (17.174). P/E Ratio (48.683) is within average values for comparable stocks, (78.986). Projected Growth (PEG Ratio) (0.934) is also within normal values, averaging (5.087). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (40.676).